Oral Contraceptive Pills Market: By Drug Type (Progestin Only Pills, Combination Pills, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography  

Oral Contraceptive Pills Market size was valued at USD 15.8 billion in 2023 and is poised to grow at a CAGR of 5.8% from 2024-2030. Oral Contraceptive Pills Market or birth control pills are the medications used to prevent pregnancy. These are hormonal preparations that contain a combination of hormones estrogen and progestin or progestin alone. The mechanism of action of oral contraceptive pills is to prevent pregnancy by inhibiting the follicle-stimulating hormone (FSH) and Luteinizing hormone (LH) which play a major role in egg development and preparation of the lining of the uterus for implantation of an embryo. Contraception is a way of preventing unplanned pregnancies, reducing the risk of sexually transmitted diseases, and controlling the birth rate (STDs).

Oral pills, injectable contraceptives, and topical contraceptives are all examples of contraception medications. These medicines are used by women of childbearing age between the ages of 15 and 44, following puberty and before menopause. Contraceptive medicines are used by a group of people to avoid pregnancy-transmitted infections (STIs), as well as for birth control and family planning. Some of the primary factors driving the growth of the global contraceptive medicines market include an increase in concerns about family planning and the need to prevent unwanted pregnancies. Furthermore, an increase in the usage of contraception among young women, as well as a rise in educational attainment, help to drive market expansion.